Related Experiment Video
Updated: Mar 24, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
[Fighting melanoma together]
18, chemin de Maltaverne, 45230 Sainte-Geneviève-des-Bois, France.
Abstract:
Patients and their families often become involved in non-profit organisations which undertake actions to combat a disease. In the case of melanoma, in addition to promoting research, associations work to encourage prevention and early detection.
Insights
Patient advocacy groups play a crucial role in combating diseases like melanoma. These non-profit organizations actively promote research, prevention, and early detection efforts.
Area of Science:
- Oncology
- Public Health
- Medical Sociology
Context:
- Non-profit organizations are increasingly involved in disease management and patient support.
- Patient and family engagement is vital for addressing health challenges.
- Melanoma presents unique challenges requiring community-driven initiatives.
Purpose:
- To highlight the multifaceted role of non-profit organizations in melanoma.
- To underscore the importance of patient advocacy in cancer control.
- To emphasize the dual focus on research promotion and public health interventions.
Summary:
- Non-profit organizations, driven by patients and families, engage in disease-specific actions.
- For melanoma, these associations champion research funding and initiatives.
- Key activities include promoting public awareness for prevention and early detection of melanoma.
Impact:
- Increased patient engagement can accelerate research breakthroughs.
- Enhanced prevention and early detection efforts improve patient outcomes.
- Community-led initiatives strengthen the overall fight against melanoma.
Related Concept Videos
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:27Tumor Immunotherapy
02:56Treatment Resistant Cancers
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
02:56Treatment Resistent Cancers